Early stage Molecular Diagnostics Partnering Forum

Date
19th Feb 2012 - 20th Feb 2012
Location
Moscone North Convention Centrer - San Francisco, San Francisco (see on map below)
Type
Partnering
URL
view event website
Organiser
Cambridge Healthtech Institute
Contact
Jim MacNeil
jmacneil@healthtech.com
001 781 072 5400

Particularly efficient for promoting discussion of partnerships, the Early Stage Molecular Diagnostics Partnering Forum is designed for both the emerging companies with promising technology and applications, and more established companies looking to collaborate with these companies. 

Reasons to Attend

  • Opportunities for scheduled one-on-one meetings and unscheduled networking with company presenters
  • 20 Companies focused on Cancer-related diagnostics
  • 40 Emerging Company Presentations including point-of-care, rapid diagnostic platforms, novel amplification and automated sample processing approaches, diagnostics for infectious disease, cardiovascular, CNS, pregnancy and other disorders
  • Panel Discussions with Program Advisors
  • Diagnostics based on DNA sequencing, genotyping and mutation analysis, gene expression signatures, protein biomarkers and protein signatures, protein post-translational modification and autoantibodies, microbiome analysis

Program Advisory Board Includes:

  • Abbott Molecular
  • BD Diagnostics
  • BioMerieux
  • Bristol Myers Squibb
  • DAKO
  • Diaceutics
  • Genomic Health
  • Gen-Probe
  • Illumina
  • LabCorp
  • Leomics Consulting
  • MDX Consulting
  • Medco Health Solutions
  • QIAGEN
  • Roche Diagnostics
  • Scientia Advisors
  • SONY DADC
  • Versant Ventures

Loading Map....